Skip to main content
. 2019 Sep 14;6(10):1949–1960. doi: 10.1002/acn3.50863

Figure 3.

Figure 3

Participant enrollment, allocation, and completion in a randomized double‐blind crossover study where the included participants with McArdle disease were allocated 1:1 to two 14‐days periods of treatment with triheptanoin and placebo in a random sequence separated by a >1‐week washout period.